Tianjin Lisheng Pharmaceutical Co.,Ltd.

SZSE:002393 Stock Report

Market Cap: CN¥4.4b

Tianjin Lisheng PharmaceuticalLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Fujun Wang

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentagen/a
CEO tenure7.3yrs
CEO ownership0.02%
Management average tenure4yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

These 4 Measures Indicate That Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Is Using Debt Safely

Sep 28
These 4 Measures Indicate That Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Is Using Debt Safely

Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Strong Profits May Be Masking Some Underlying Issues

Mar 28
Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Strong Profits May Be Masking Some Underlying Issues

CEO

Fujun Wang (56 yo)

7.3yrs

Tenure

CN¥1,026,000

Compensation

Mr. Fujun Wang has been a Non-Independent Director of Tianjin Lisheng Pharmaceutical Co.,Ltd. since August 17, 2017 and serves as its General Manager.


Leadership Team

NamePositionTenureCompensationOwnership
Fujun Wang
GM & Non-Independent Directorno dataCN¥1.03m0.022%
CN¥ 970.3k
Jiaying Wang
Financial Director & Accounting Supervisor3.2yrsCN¥602.30k0.018%
CN¥ 776.2k
Feifei Ma
Secretary of the Board11yrsCN¥718.50k0.018%
CN¥ 776.2k
Changfeng Long
Chief Engineer & Deputy GM4.9yrsCN¥802.20k0.018%
CN¥ 776.2k
Xiaoyan Guo
Deputy General Managerno dataCN¥729.20k0.018%
CN¥ 776.2k
Jiankang Liang
Deputy General Manager2.3yrsCN¥528.50k0.018%
CN¥ 776.2k

4.0yrs

Average Tenure

49.5yo

Average Age

Experienced Management: 002393's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fujun Wang
GM & Non-Independent Director7.3yrsCN¥1.03m0.022%
CN¥ 970.3k
Qian Wang
Director1.6yrsCN¥781.70k0.018%
CN¥ 776.2k
Kexiang Yu
Non-Independent Director2.8yrsno datano data
Ying Lei
Independent Director3yrsCN¥60.00kno data
Jianxin Fang
Independent Director4yrsCN¥60.00kno data
Mei Zhang
Independent Director4yrsCN¥60.00kno data
Liyan Zhu
Supervisor2.4yrsno datano data
Ping Zhang
Chairman of the Board2.1yrsCN¥833.00k0.022%
CN¥ 970.3k
Fei Teng
Director1.6yrsno datano data
Lijun Sun
Chairman of the Board of Supervisors1.6yrsno datano data
Hao Liu
Director2.4yrsno datano data
Qiong Wang
Supervisor1.7yrsno datano data

2.4yrs

Average Tenure

52yo

Average Age

Experienced Board: 002393's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:32
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tianjin Lisheng Pharmaceutical Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peng YanChangjiang Securities Co. LTD.
Jie YaoEverbright Securities Co. Ltd.
Ting HuangSinolink Securities Co., Ltd.